As the country responds to the COVID-19 pandemic, life sciences companies as well as manufacturers that do not normally produce medical devices are coming together to fill the vast gaps in availability of supplies of critical medical equipment. As a result, many manufacturers are grappling with questions about their newly expanded products liability risk profiles.
In this special edition webinar series, Medmarc defense panel member, Jordan Lipp, Managing Member, Childs McCune, will lead discussions on two topics critical to products liability risk mitigation.
This session is a discussion about the PREP Act and its liability immunity implications for companies responding to the COVID-19 pandemic.
Jordan Lipp | Partner | Childs McCune
Jordan Lipp is a partner at Childs McCune LLC in Denver, Colorado, where he focuses his practice on product liability defense, outdoor industry defense, and commercial litigation. He wrote the book on product liability law in Colorado – Product Liability Law & Procedure in Colorado, 2nd Edition (2019) – and he is an adjunct law professor at University of Denver’s Sturm College of Law. He can be reached at firstname.lastname@example.org or 720-630-2952.